Suppliers told to increase production of H1N1 vaccine
Faced with an acute shortage of nasal syringes for delivering the intra-nasal H1N1 vaccine, Nasovac, the Serum Institute of India (SII) has questioned all its suppliers to increase production capacity with immediate effect.
The company went into a supply shortage situation last week with nasal syringes running out of stock. Consequently, suppliers were questioned to increase their production capacity at the earliest, Adar Poonawalla, co-owner and executive director SII said.Nasovac kit is sold for Rs158 each.
Since April, a total of 1,373 cases have tested positive for H1N1 in Pune district with 135 deaths of which more than 90 occurred in the past month. The demand for the vaccine has been coming in from Pune and other parts of the country.
Ever since its launch on July 14, the company sold over 10 lakh doses of the vaccine while another 5 lakh doses have been distributed free of cost to different agencies.
The US-based Becton-Dickinson and Company, city-based Taurus Bio Medical Aids Private Limited and Hindustan Syringes and Medical Devices Private Limited, Delhi, are among the suppliers who have been questioned to increase production and ensure quicker delivery.
According to Poonawalla, Serum has sold nearly 10 lakh doses so far and estimates that the demand could rise to nearly 20 lakh doses every month from now.
Serum’s head of vaccine production unit, Dr Rajeev Dhere, acknowledged that there was a shortage which has since been addressed.
Source: http://www.dnaindia.com/mumbai/report_suppliers-told-to-increase-production-of-h1n1-vaccine_1425005
Related posts:
7 Responses to “Suppliers told to increase production of H1N1 vaccine”
Leave a Reply
You must be logged in to post a comment.
August 18th, 2010 at 6:39 am
Yeah..! We should be aware of the importance of vaccination especially now a days when sickness like h1n1 is spreading like a plague.
August 18th, 2010 at 2:11 pm
The proces should be keept under maintenances, since there is nothing to dread about. Though on the market someone needs to make some simple money
August 18th, 2010 at 2:46 pm
The H1N1 was preventable. What was contained in one country (Mexico) spread into other countries, including what we call the less developed eventhough is one of the most traveled to places.
I am assuming Foreigners had a lot to do with this issue but they aren't suffering from the burdens as a result of the spread. It is the original innocent civilians of the country that are suffering intensively either by taxes, budget cuts, social roles, lost lives, sever injuries, time wasted in hospitalization, expenditures and post care for the injury. While the other flees unnoticed but gets treated in some private first world clinic.
Globalization has its benefits, and it is mainly for the businessmen and industrialists to conduct business in a mutual, face to face cooperative and healthy manner but much of the globalization is done by regular people that want to explore a different territory. There must be precautions for those people that venture out unknowingly of their illnesses. Some screening process should be initiated right on the spot of the country that they depart from.
August 23rd, 2010 at 3:13 am
A very comprehensive article on H1N1 with fantastic and valuable pointers here that I had never known of. Thanks for passing on this info.
August 23rd, 2010 at 4:40 pm
I would be reckon twice before get any vaccine, that is about side effects, which could be really bed.
August 27th, 2010 at 6:49 am
We should certainly increase H1N1 vaccine production. Health organizations should not wait for emergency situation before making a plot. I still believe in the saying that Prevention is worth a pound of cure."
August 30th, 2010 at 7:56 am
This was a very nice read on H1N1 with a lot of significant information within. Awesome article by the author! Thanks for sharing this with us.